Paper42935682PubMed
Exploring the protective mechanism of Huangqishengmaiyin against anthracycline-induced cardiotoxicity in breast cancer with concomitant gut microbiota modulation.
Wang Y and 6 others. Front Cardiovasc Med, 2026.
Cite this record
ConductScience Library. Exploring the protective mechanism of Huangqishengmaiyin against anthracycline-induced cardiotoxicity in breast cancer with concomitant gut microbiota modulation. Papers, record 42935682. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42935682
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Exploring the protective mechanism of Huangqishengmaiyin against anthracycline-induced cardiotoxicity in breast cancer with concomitant gut microbiota modulation.
- Journal
- Front Cardiovasc Med
- Year
- 2026
- Publication types
- Journal Article
- Revised in PubMed
- 2026-10-28
Source PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References43
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 42417444 | Global cancer statistics 2024: GLOBOCAN estimates of incidence and mortality worldwide for 34 cancers in 186 countries. | CA Cancer J Clin | 2026 | https://conductscience.org/library/papers/42417444 | PubMed |
| 2 | 39179485 | Therapeutic inhibition of the JAK-STAT pathway in the treatment of inflammatory bowel disease. | Cytokine Growth Factor Rev | 2024 | https://conductscience.org/library/papers/39179485 | PubMed |
| 3 | 36623754 | Research progress of natural medicine Astragalus mongholicus Bunge in treatment of myocardial fibrosis. | J Ethnopharmacol | 2023 | https://conductscience.org/library/papers/36623754 | PubMed |
| 4 | 39417505 | KEGG: biological systems database as a model of the real world. | Nucleic Acids Res | 2025 | https://conductscience.org/library/papers/39417505 | PubMed |
| 5 | 37301317 | Gut barrier dysfunction and endotoxemia in heart failure: A dangerous connubium? | Am Heart J | 2023 | https://conductscience.org/library/papers/37301317 | PubMed |
| 6 | 35987015 | Glycosides from Buyang Huanwu Decoction inhibit atherosclerotic inflammation via JAK/STAT signaling pathway. | Phytomedicine | 2022 | https://conductscience.org/library/papers/35987015 | PubMed |
| 7 | 17942826 | Dose translation from animal to human studies revisited. | FASEB J | 2008 | https://conductscience.org/library/papers/17942826 | PubMed |
| 8 | 34502383 | Chemotherapy-Induced Intestinal Microbiota Dysbiosis Impairs Mucosal Homeostasis by Modulating Toll-like Receptor Signaling Pathways. | Int J Mol Sci | 2021 | https://conductscience.org/library/papers/34502383 | PubMed |
| 9 | 34416387 | Microbiota modulate Doxorubicin induced cardiotoxicity. | Eur J Pharm Sci | 2021 | https://conductscience.org/library/papers/34416387 | PubMed |
| 10 | 31441146 | Toward understanding the origin and evolution of cellular organisms. | Protein Sci | 2019 | https://conductscience.org/library/papers/31441146 | PubMed |
| 11 | 38801910 | Effect of shenmai injection on anthracycline-induced cardiotoxicity: A systematic review and meta-analysis. | Complement Ther Med | 2024 | https://conductscience.org/library/papers/38801910 | PubMed |
| 12 | 35905252 | Cardioprotective effect of Chinese herbal medicine for anthracycline-induced cardiotoxicity in cancer patients: A meta-analysis of prospective studies. | Medicine (Baltimore) | 2022 | https://conductscience.org/library/papers/35905252 | PubMed |
| 13 | 38773999 | Dexrazoxane to Prevent Cardiotoxicity in Adults Treated with Anthracyclines: JACC: CardioOncology Controversies in Cardio-Oncology. | JACC CardioOncol | 2024 | https://conductscience.org/library/papers/38773999 | PubMed |
| 14 | 39575489 | Ophiopogon japonicus polysaccharide reduces doxorubicin-induced myocardial ferroptosis injury by activating Nrf2/GPX4 signaling and alleviating iron accumulation. | Mol Med Rep | 2025 | https://conductscience.org/library/papers/39575489 | PubMed |
| 15 | 37187275 | Regulation of the JAK/STAT signaling pathway: The promising targets for cardiovascular disease. | Biochem Pharmacol | 2023 | https://conductscience.org/library/papers/37187275 | PubMed |
| 16 | 41378248 | Gut microbiome and chemotherapy-induced cardiotoxicity: A systematic review of evidence and emerging therapies. | World J Biol Chem | 2025 | https://conductscience.org/library/papers/41378248 | PubMed |
| 17 | 38720361 | Role of gut microbiota in doxorubicin-induced cardiotoxicity: from pathogenesis to related interventions. | J Transl Med | 2024 | https://conductscience.org/library/papers/38720361 | PubMed |
| 18 | 29141545 | Main Isoflavones Found in Dietary Sources as Natural Anti-inflammatory Agents. | Curr Drug Targets | 2018 | https://conductscience.org/library/papers/29141545 | PubMed |
| 19 | 39398983 | Coumarin: A natural solution for alleviating inflammatory disorders. | Curr Res Pharmacol Drug Discov | 2024 | https://conductscience.org/library/papers/39398983 | PubMed |
| 20 | 18006777 | Schisandrin B prevents doxorubicin-induced cardiotoxicity via enhancing glutathione redox cycling. | Clin Cancer Res | 2007 | https://conductscience.org/library/papers/18006777 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Cited by
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/42935682
GET https://conductscience.org/api/papers/v1/42935682/references?page=2